Camptocormia in Parkinson disease: an epidemiological and clinical study

D Tiple
February 2009
Journal of Neurology, Neurosurgery & Psychiatry;Feb2009, Vol. 80 Issue 2, p145
Academic Journal
BACKGROUND: Camptocormia is an abnormal flexion of the thoracolumbar spine during standing and walking that abates in the recumbent position. METHODS: In a single-centre epidemiological and clinical study, the prevalence of camptocormia in Parkinson disease (PD) and its relationship with the clinical features of PD were investigated. A total of 275 consecutive outpatients were systematically screened for camptocormia with a clinical evaluation. Patients who screened positive for camptocormia were subsequently reassessed by formal goniometric analysis. The demographic and clinical features of the patients with and without camptocormia were then compared. RESULTS: A 6.9% (19/275, 95% CI, 4.2 to 10.6) prevalence of camptocormia was found. Camptocormia was found in patients with more severe PD, as clinically assessed by the Hoehn–Yahr (HY) staging and the motor Unified Parkinson Disease Rating Scale (UPDRS) part III, longer L-dopa treatment duration and greater L-dopa daily dose and presence of DSM-IV dementia. Camptocormia was reported to develop after the clinical onset of PD. No correlation was found between the degree of trunk flexion and age, duration of PD, UPDRS motor score, HY staging, and L-dopa treatment duration and dose. As a risk factor, the study identified previous vertebral surgery. CONCLUSIONS: Camptocormia, a relatively common sign in PD seems to be related to the clinical severity of PD.


Related Articles

  • The role of levodopa in the management of dementia with Lewy bodies. Molloy, S.; McKeith, I. G.; O'Brien, J. T.; Burn, D. J. // Journal of Neurology, Neurosurgery & Psychiatry;Sep2005, Vol. 76 Issue 9, p1200 

    Background: One of the core clinical features of dementia with Lewy bodies (DLB) is extrapyramidal syndrome (EPS). Levodopa is currently the gold standard oral therapy for Parkinson's disease (PD), but its use in DIB has been tempered by concerns of exacerbating neuropsychiatric symptoms. Aim:...

  • Presynaptic nigro-striatal function in a group of Alzheimer’s disease patients with parkinsonism: evidence from a dopamine transporter imaging study. Ceravolo, R.; Volterrani, D.; Gambaccini, G.; Bernardini, S.; Rossi, C.; Logi, C.; Tognoni, G.; Manca, G.; Mariani, G.; Bonuccelli, U.; Murri, L. // Journal of Neural Transmission;Aug2004, Vol. 111 Issue 8, p1065 

    Summary. The occurrence of parkinsonism in Alzheimer’s disease (AD) is quite common, however the molecular and neurochemical changes underlying such extrapyramidal features in AD have been not fully understood. Post-mortem as well as in vivo imaging study have produced conflicting results...

  • Conference News Update.  // Neurology Reviews;Jul2011, Vol. 19 Issue 7, p13 

    The article focuses on the studies presented at the 15th International Congress of Parkinson's Disease and Movement Disorders by the Movement Disorder Society in Toronto, Ontario. It highlights the study from the Donders Institute for Brain which addresses the significance of cycling in the...

  • Identifying an Underserved Population for Speech-Language Pathology. Ervin, Margaret // ASHA Leader;12/05/2000, Vol. 5 Issue 23, p11 

    Comments on the study `Spoken Language Production in Huntington's and Parkinson's Diseases,' by Laura Murray, which appeared in the August 2000 issue of the `Journal of Speech, Language, and Hearing Research.' Overview of the study; Implications of the study on speech therapy clinicians who...

  • The tauopathy associated with mutation +3 in intron 10 of Tau: characterization of the MSTD family. Salvatore Spina; Martin R. Farlow; Frederick W. Unverzagt; David A. Kareken; Jill R. Murrell; Graham Fraser; Francine Epperson; R. Anthony Crowther; Maria G. Spillantini; Michel Goedert; Bernardino Ghetti // Brain: A Journal of Neurology;Jan2008, Vol. 131 Issue 1, p72 

    Multiple system tauopathy with presenile dementia (MSTD) is an inherited disease caused by a (g) to (a) transition at position +3 in intron 10 of Tau. It belongs to the spectrum of frontotemporal dementia and parkinsonism linked to chromosome 17 with mutations in Tau (FTDP-17T). Here we present...

  • Bradykinesia in Huntington's disease. A prospective, follow-up study. Ruiz, Pedro J. García; Hernández, Jaime; Cantarero, Susana; Bartolomé, Manuel; Bernardos, Vicenta Sánchez; de Yébenez, Justo García // Journal of Neurology;Apr2002, Vol. 249 Issue 4, p437 

    Bradykinesia is a frequent finding in Huntington's disease (HD), but some aspects are presently unknown; including the natural evolution of bradykinesia over time and the correlation between bradykinesia and functional capacity. We studied the motor performance of 20 genetically confirmed...

  • Editorial: Neurotherapeutics of Movement Disorders. Factor, Stewart; Jankovic, Joseph // Neurotherapeutics;Jan2014, Vol. 11 Issue 1, p3 

    An introduction to the journal is presented in which the editor discusses the topics including advances in the treatment of Parkinson's disease, therapies in hyperkinetic movement disorders which include Huntington's disease and Tourette's syndrome, and design of therapeutic interventions.

  • Rapidly-administered short forms of the Wechsler Adult Intelligence Scale—3rd edition Donnell, Alison J.; Pliskin, Neil; Holdnack, James; Axelrod, Bradley; Randolph, Christopher // Archives of Clinical Neuropsychology;Nov2007, Vol. 22 Issue 8, p917 

    Abstract: Although the Wechsler Full Scale IQ (FSIQ) is a common component of most neuropsychological evaluations, there are many clinical situations where the complete administration of this battery is precluded by various constraints, including limitations of time and patient compliance. These...

  • Epigenetyka a etiologia chorób neurodegeneracyjnych. Gruber, Beata M. // Advances in Hygiene & Experimental Medicine / Postepy Higieny i ;2011, Vol. 65, p542 

    Determination of specific gene profile expression is essential for morphological and functional differentiation of cells in the human organism. The human genome consists of 25-30 thousands genes but only some of them are expressed in each cell. Epigenetic modifications such as DNA methylation,...


Read the Article


Sign out of this library

Other Topics